SCHEMBL21189437

SCHEMBL21189437

COC(=O)N[C@H]1CCSc2c(C(=O)Nc3ccc(F)c(F)c3)ccc(F)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 5/20 0.39
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 5/20 0.39
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
LMNA P02545 2/20 0.37
APOB P04114 1/20 0.37
MTTP P55157 1/20 0.37
POLB P06746 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21189201 1.00 MEN1 (0.39) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL21189215 0.91 KMT2A (0.44) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL19973708 0.91 KMT2A (0.44) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL21189387 0.91 KMT2A (0.44) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL26715124 0.90 TP53 (0.40) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL19973550 0.89 TP53 (0.43) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL19973955 0.89 TP53 (0.43) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL19973882 0.89 TP53 (0.43) MEN1KMT2ANPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL19973582 0.88 TP53 (0.42) MEN1KMT2ANPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL19973578 0.88 TP53 (0.42) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS MEN1 1933/4885KMT2A 155/4885NPC1 983/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS MEN1 1933/4885KMT2A 155/4885NPC1 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.